A
XFOR icon

AJOVista’s X4 Pharmaceuticals XFOR Stock Holding History

AJOVista’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$172K Buy
+8,588
New +$179K 0.74% 44

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

AJOVista's XFOR Position: Q3 2024 in Review

AJOVista opened a new position in X4 Pharmaceuticals (XFOR) in Q3 2024: 8,588 shares worth $172K. The stake represents 0.74% of the portfolio and ranks #44 among its holdings.

97 funds tracked by Wall St. Rank hold XFOR as of Q3 2024.

  • AJOVista held 8,588 shares of X4 Pharmaceuticals worth $172K as of Q3 2024.
  • X4 Pharmaceuticals was a new AJOVista position in Q3 2024.
  • X4 Pharmaceuticals made up 0.74% of AJOVista's portfolio in Q3 2024, its #44 holding.
  • 97 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.